Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 3,913	$ 4,030
Receivables:
Receivable from the sale of IQOS System commercialization rights	1,746	1,721
Other	58	48
Inventories:
Leaf tobacco	664	704
Other raw materials	202	186
Work in process	30	24
Finished product	356	266
Inventory, net	1,252	1,180
Other current assets	183	241
Total current assets	7,152	7,220
Property, plant and equipment, at cost	4,413	4,427
Less accumulated depreciation	2,820	2,819
Property, plant and equipment, net	1,593	1,608
Goodwill	5,177	5,177
Other intangible assets, net	12,366	12,384
Investments in equity securities ($0 million and $250 million at March 31, 2023 and December 31, 2022, respectively, measured at fair value)	9,559	9,600
Other assets	979	965
Total Assets	36,826	36,954
Liabilities
Current portion of long-term debt	1,339	1,556
Accounts payable	412	552
Accrued liabilities:
Marketing	587	599
Settlement charges	3,820	2,925
Other	1,303	1,299
Dividends payable	1,685	1,685
Total current liabilities	9,146	8,616
Long-term debt	24,048	25,124
Deferred income taxes	2,735	2,897
Accrued pension costs	128	133
Accrued postretirement health care costs	1,086	1,083
Deferred gain from the sale of IQOS System commercialization rights	2,700	2,700
Other liabilities	809	324
Total liabilities	40,652	40,877
Contingencies (Note 11)
Stockholders’ Equity (Deficit)
Common stock, par value $0.33 1/3 per share (2,805,961,317 shares issued)	935	935
Additional paid-in capital	5,866	5,887
Earnings reinvested in the business	29,898	29,792
Accumulated other comprehensive losses	(2,779)	(2,771)
Cost of repurchased stock (1,019,815,657 shares at March 31, 2023 and 1,020,427,195 shares at December 31, 2022)	(37,796)	(37,816)
Total stockholders’ equity (deficit) attributable to Altria	(3,876)	(3,973)
Noncontrolling interests	50	50
Total stockholders’ equity (deficit)	(3,826)	(3,923)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 36,826	$ 36,954